NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE51676 Query DataSets for GSE51676
Status Public on Dec 10, 2015
Title Molecular characterization of chronic antibody mediated rejection in kidney transplantation (microRNA)
Organism Homo sapiens
Experiment type Non-coding RNA profiling by array
Summary Chronic antibody-mediated rejection (CAMR) represents the main cause of kidney graft loss, but its pathogenesis is unclear. In order to uncover the molecular mechanisms underlying this condition, we characterized the molecular signature of circulating peripheral blood mononuclear cells and, separately, of CD4+ T lymphocytes isolated from CAMR patients compared to kidney transplant recipients with normal graft function and histology.
In total peripheral lympho-monocytes, forty-five genes resulted differentially expressed between the two groups, most of them were up-regulated in CAMR and were involved in type I interferon signaling. In addition, in the same set of patients, 16 microRNAs resulted down-regulated in CAMR subjects compared to controls: 4 were predicted modulators of 6 mRNAs identified in the transcriptional analysis. In silico functional analysis supported the involvement of type I interferon signaling. To further confirm this hypothesis, we investigated the transcriptomic profiles of CD4+ T lymphocytes in an independent group of patients and we observed that the activation of type I interferon signaling was a specific hallmark of CAMR. In addition, in CAMR patients we detected a reduction of circulating BDCA2+ dendritic cells, the natural type I interferon- producing cells and their recruitment into the graft along with an increased expression of MXA, a type I interferon-induced protein, at tubulointerstitial and vascular level.
In conclusion, our data suggest that type I interferon signaling may represent the molecular signature of CAMR.

 
Overall design For microarray analysis, we studied 5 patients included into the control-group and 4 included into the study group. The control group was represented by renal transplant recipients undergoing protocol graft biopsies, with normal renal function and histology, in the absence of circulating anti-HLA antibodies. Study group patients showed clinical and histological evidence of CAMR according to Banff 2011 criteria.
 
Contributor(s) Rascio F, Pontrelli P, Accetturo M, Oranger A, Gigante M, Castellano G, Gigante M, Zito A, Zaza G, Lupo A, Ranieri E, Stallone G, Gesualdo L, Grandaliano G
Citation(s) 25925804
Submission date Oct 24, 2013
Last update date Dec 10, 2015
Contact name Paola Pontrelli
E-mail(s) paola.pontrelli@uniba.it
Phone +390805478868
Organization name University of Bari
Department Dept. of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J)
Lab Nephrology Unit
Street address Piazza G.Cesare 11
City Bari
ZIP/Postal code 70124
Country Italy
 
Platforms (1)
GPL16770 Agilent-031181 Unrestricted_Human_miRNA_V16.0_Microarray (miRBase release 16.0 miRNA ID version)
Samples (9)
GSM1250409 PBMC_CAMR_Patient 3
GSM1250410 PBMC_CAMR_Patient 8
GSM1250411 PBMC_CAMR_Patient 9
Relations
BioProject PRJNA224309

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE51676_RAW.tar 25.8 Mb (http)(custom) TAR (of TXT)
GSE51676_normalized.txt.gz 30.3 Kb (ftp)(http) TXT
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap